Referrals and red flag symptom training: Your CPCS queries answered

How many referrals pharmacies should expect and whether call handlers are trained to spot red flag symptoms were just two topics discussed during C+D's live Q&A on the CPCS.

CPCS%20ANDRE%20YEUNG%20INTERVIEW.jpg
Mr Yeung answered pharmacists' questions about the CPCS in a live Q&A last night

C+D sat down with Andre Yeung, one of the architects behind the pilot that inspired the Community Pharmacist Consultation Service (CPCS), to answer pharmacists' questions on the service in a live webinar last night (December 10). 

The interview featured questions submitted by C+D readers on various topics, including the service basics, what types of referrals pharmacists will receive, and how to manage the workload.

Watch the full interview in the video below. (Skip to 8.45 minutes for the start of​ the Q&A)

Number of patients coming through the CPCS

In response to a question about the number of NHS 111 referrals to expect via the service, Mr Yeung said it is “really difficult” to put an exact figure on it, as it is dependent on many variables.

However, “patients that are calling 111 are usually calling when a GP practice has closed”, he explained.

This “spike” in calls means pharmacies open after GP surgeries have typically closed, or at the weekend, are likely to receive more patient referrals via the CPCS, Mr Yeung said.

Call handler training

Mr Yeung also addressed pharmacists’ concerns at receiving referrals for patients with “obvious red flags”, who questioned whether the NHS 111 call handlers had had appropriate training on who to refer patients to in these cases.

“That is something that pharmacists have to bear in mind,” Mr Yeung said. “You've got a non-healthcare professional answering the phone, not being able to see the person that they're talking to, so it is very difficult already to get a steer on that.

“What [call handlers] are doing is following an algorithm and basing entirely what happens with that patient off the back of what that patient tells them,” he explained.

“When the patient attends the pharmacy, it's for the pharmacist to carry out the clinical assessment. They're the first healthcare professional that's been involved in assessing that patient, and it's the pharmacist that then decides what's appropriate and what's not.”

Mr Yeung urged pharmacists not to get “frustrated” if a patient is referred to them with red flag symptoms, as “that is part of what we are expecting pharmacists to do as part of the [service]”.

Watch the full video to hear Mr Yeung's advice on:

  • Whether independent prescribers can treat a patient privately if they are referred by NHS 111
  • How to ensure that locums receive support to provide the CPCS
  • How and when pharmacists should handle requests for quantities of controlled drugs schedule 4 and 5

Sign in or register for free

Latest from News

RPS to become Royal College of Pharmacy after 31% voter turnout

 
• By 
 • comment0

Seven in ten Royal Pharmaceutical Society (RPS) members who took part in the ballot have voted in favour of controversial plans for the body to become a royal college and register as a charity.

New evidence Brexit caused UK medicines shortages

 
• By 
 • comment0

A health and social care think tank has revealed that the “elevated and troubling level” of medicine shortages in the UK can be blamed on Brexit.

Risk pharmacies ‘deprioritised’ if GP role grows, report warns

 
• By 
 • comment1

A Westminster think tank has said that the government’s proposed Neighbourhood Health Service, which plans to scale up general practice, could put community pharmacies at risk of being “deprioritised”.

More from Clinical

Al-Hassan: Pharmacy prescribing service ‘two or three years’ away

 
• By 
 • comment

MP and pharmacist Sadik Al-Hassan has said the promised community pharmacy prescribing service is “deliverable” but not ready yet.

Pharmacies to boost naloxone stock amid ‘sudden’ overdose spike

 
• By 
 • comment

Pharmacies in Scotland have been asked to ensure they have the “appropriate stock” of naloxone – a medicine used to reverse the effects of an opiate overdose – following an “increase in sudden collapse” due to overdoses.